Likewise, the majority of tumor-bearing mice succumbed to T cell lymphoma or solid tumors both in R26+/+Cd19+/creTp53-/- and in R26+/AIDCd19+/creTp53-/- mice (65% and 77% combined frequency, respectively). This evidence concerns the gene CD19 and neoplasm.